A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis

COVID-19 is a global pandemic associated with increased morbidity and mortality. Convalescent plasma (CP) infusion is a strategy of potential therapeutic benefit. We conducted a multicenter phase II study to evaluate the efficacy and safety of CP in patients with COVID-19, grade 4 or higher. To eval...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Microorganisms
Главные авторы: Pappa, Vasiliki, Bouchla, Anthi, Terpos, Evangelos, Thomopoulos, Thomas P., Rosati, Margherita, Stellas, Dimitris, Antoniadou, Anastasia, Mentis, Andreas, Papageorgiou, Sotirios G., Politou, Marianna, Kotanidou, Anastasia, Kalomenidis, Ioannis, Poulakou, Garyfalia, Jahaj, Edison, Korompoki, Eleni, Grigoropoulou, Sotiria, Hu, Xintao, Bear, Jenifer, Karaliota, Sevasti, Burns, Robert, Pagoni, Maria, Trontzas, Ioannis, Grouzi, Elisavet, Labropoulou, Stavroula, Stamoulis, Kostantinos, Bamias, Aristotelis, Tsiodras, Sotirios, Felber, Barbara K., Pavlakis, George N., Dimopoulos, Meletios- Athanasios
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2021
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8069820/
https://ncbi.nlm.nih.gov/pubmed/33920489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/microorganisms9040806
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы